Patents by Inventor Sandhya Kortagere

Sandhya Kortagere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS AND METHODS OF TREATING OR AMELIORATING AN IL-1R-MEDIATED DISEASE OR DISORDER USING SAME
    Publication number: 20180030046
    Abstract: The present invention provides compounds useful for treating or preventing an IL-1R-mediated disease or disorder. In certain embodiments, the disease or disorder comprises scleroderma.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 1, 2018
    Inventors: Sandhya KORTAGERE, Carol M. ARTLETT
  • Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
    Patent number: 9861594
    Abstract: The present invention provides a method of treating or preventing an attention and/or cognitive disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention. The present invention further provides a method of treating or preventing dementia associated with a neurodegenerative disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: January 9, 2018
    Assignee: Drexel University
    Inventor: Sandhya Kortagere
  • NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE
    Publication number: 20170246128
    Abstract: The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.
    Type: Application
    Filed: April 26, 2017
    Publication date: August 31, 2017
    Inventors: Sandhya KORTAGERE, Eldo V. KUZHIKANDAHIL
  • NOVEL COMPOUNDS AND METHODS OF TREATING OR AMELIORATING AN IL-1R-MEDIATED DISEASE OR DISORDER USING SAME
    Publication number: 20170204089
    Abstract: The present invention provides compounds useful for treating or preventing an IL-1R-mediated disease or disorder. In certain embodiments, the disease or disorder comprises scleroderma.
    Type: Application
    Filed: August 3, 2015
    Publication date: July 20, 2017
    Inventors: Sandhya KORTAGERE, Carol M. ARTLETT
  • NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME
    Publication number: 20170190709
    Abstract: The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
    Type: Application
    Filed: December 16, 2016
    Publication date: July 6, 2017
    Inventors: Sandhya KORTAGERE, Ole MORTENSEN, Andreia C. K. MORTENSEN, Joseph M. SALVINO
  • D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
    Patent number: 9675565
    Abstract: The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: June 13, 2017
    Assignees: Drexel University, Rutgers, The State University of New Jersey
    Inventors: Sandhya Kortagere, Eldo V. Kuzhikandahil
  • Compositions useful in treating brain-related diseases or disorders and methods using same
    Patent number: 9616065
    Abstract: The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, the method comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: April 11, 2017
    Assignee: Drexel University
    Inventors: Sandhya Kortagere, Ole Valente Mortensen, Andreia C. K. Mortensen, Joseph M. Salvino
  • Anti-malarial agents
    Patent number: 9464057
    Abstract: The present invention is related to a use of pyrazole derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to pyrazole derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: October 11, 2016
    Assignees: MMV MEDICINES FOR MALARIA VENTURE, DREXEL UNIVERSITY, UNIVERSITY OF WASHINGTON
    Inventors: Jeremy Burrows, Matthew Wyvratt, Akhil Vaidya, Sandhya Kortagere, Erkang Fan, Arnab Kumar Chatterjee, Advait Suresh Nagle, Tomoyo Kato
  • NOVEL TREATMENTS FOR ATTENTION AND COGNITIVE DISORDERS, AND FOR DEMENTIA ASSOCIATED WITH A NEURODEGENERATIVE DISORDER
    Publication number: 20160256417
    Abstract: The present invention provides a method of treating or preventing an attention and/or cognitive disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention. The present invention further provides a method of treating or preventing dementia associated with a neurodegenerative disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 8, 2016
    Applicant: Drexel University
    Inventor: Sandhya KORTAGERE
  • NEW ANTI-MALARIAL AGENTS
    Publication number: 20160194286
    Abstract: The present invention is related to a use of pyrazole derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to pyrazole derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
    Type: Application
    Filed: July 17, 2014
    Publication date: July 7, 2016
    Inventors: JEREMY BURROWS, MATTHEW WYVRATT, AKHIL VAIDYA, SANDHYA KORTAGERE, ERKANG FAN, ARNAB KUMAR CHATTERJEE, ADVAIT SURESH NAGLE, TOMOYO KATO
  • Ddopamine receptor agonists to treat dyskinesia in parkinson's disease
    Patent number: 9289400
    Abstract: The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: March 22, 2016
    Assignees: Drexel University, Rutgers, The State University of New Jersey
    Inventors: Sandhya Kortagere, Eldo V. Kuzhikandahil
  • NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME
    Publication number: 20160074408
    Abstract: The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, the method comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
    Type: Application
    Filed: April 16, 2014
    Publication date: March 17, 2016
    Applicant: Drexel University
    Inventors: Sandhya KORTAGERE, Ole Valente MORTENSEN, Andreia C.K. MORTENSEN
  • Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
    Publication number: 20140228380
    Abstract: The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.
    Type: Application
    Filed: August 2, 2013
    Publication date: August 14, 2014
    Applicants: University of Medicine and Dentistry New Jersey Medical School, Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine
    Inventors: Sandhya Kortagere, Eldo V. Kuzhikandahil
  • Mechanism-based small-molecule parasite inhibitors
    Patent number: 8486987
    Abstract: Methods for preventing or treating an Apicomplexan parasite infection in a patient administering to a patient in need thereof an effective amount of a compound of Formulas I-IV.
    Type: Grant
    Filed: November 16, 2008
    Date of Patent: July 16, 2013
    Assignees: University of Medicine and Dentistry of New Jersey, Philadelphia Health and Education Corporation
    Inventors: William J. Welsh, Sandhya Kortagere, Lawrence W. Bergman, Akhil B. Vaidya
  • Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
    Publication number: 20130165489
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing a viral infection in a subject, comprising administering to the subject a pharmaceutical composition comprising one or more of the compounds useful within the invention.
    Type: Application
    Filed: April 25, 2011
    Publication date: June 27, 2013
    Applicants: The Trustees of the University of Pennsylvania, Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine
    Inventors: Simon Cocklin, Sandhya Kortagere, Amos B. Smith, III
  • MECHANISM-BASED SMALL-MOLECULE PARASITE INHIBITORS
    Publication number: 20110172268
    Abstract: Methods for preventing or treating an Apicomplexan parasite infection in a patient administering to a patient in need thereof an effective amount of a compound of Formulas I-IV.
    Type: Application
    Filed: November 16, 2008
    Publication date: July 14, 2011
    Applicants: University of Medicine and Dentistry of New Jersey, Philadelphia Health And Education Corporation D/b/a Drexel University College of Medicine
    Inventors: William J. Welsh, Sandhya Kortagere, Lawrence W. Bergman, Akhil B. Vaidya